Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dr Reddy's Laboratories

13.81
+0.14001.02%
Volume:125.09K
Turnover:1.73M
Market Cap:11.51B
PE:18.37
High:13.84
Open:13.80
Low:13.75
Close:13.67
Loading ...

Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US

MT Newswires Live
·
13 Mar

Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection

TIPRANKS
·
13 Mar

Morgans Remains a Buy on ReadyTech Holdings Ltd. (RDY)

TIPRANKS
·
04 Mar

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey
·
02 Mar

ReadyTech Holdings First Half 2025 Earnings: AU$0.16 loss per share (vs AU$0.018 profit in 1H 2024)

Simply Wall St.
·
01 Mar

Macquarie downgrades ReadyTech Holdings Ltd. (RDY) to a Hold

TIPRANKS
·
28 Feb

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
27 Feb

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey
·
27 Feb

ReadyTech Holdings Ltd. (RDY) Gets a Buy from Jefferies

TIPRANKS
·
27 Feb

Shaw and Partners Remains a Buy on ReadyTech Holdings Ltd. (RDY)

TIPRANKS
·
27 Feb

Asian Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading

MT Newswires Live
·
24 Feb

RIGL Stock Surges 41.4% in a Year: Time to Buy or Sell?

Zacks
·
24 Feb

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, Up 2.2% for Week

MT Newswires Live
·
21 Feb

Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

MT Newswires Live
·
13 Feb

Do Fundamentals Have Any Role To Play In Driving ReadyTech Holdings Limited's (ASX:RDY) Stock Up Recently?

Simply Wall St.
·
07 Feb

Dr. Reddy's Laboratories Has Licensing Deal for Potential Multiple Myeloma Treatment

MT Newswires Live
·
06 Feb

Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading

MT Newswires Live
·
06 Feb

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe

Business Wire
·
06 Feb

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

PR Newswire
·
06 Feb

Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading

MT Newswires Live
·
31 Jan